NCT02491671View on ClinicalTrials.gov

Effectiveness Novel Tissue Sealant, Prevention Prolonged Air Leak (PAL) After Lung Resection

PHASE3CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

November 24, 2015

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Prolonged Air LeakLung Resection
Interventions
DEVICE

Hemopatch

PROCEDURE

standard preventive measures

Trial Locations (6)

28034

Hospital Universitario Ramón y Cajal de Madrid, Madrid

28040

Hospital Clínico San Carlos, Madrid

37007

Hospital Universitario de Salamanca (CAUSA), Salamanca

39008

Hospital Universitario Marqués de Valdecilla de Santander, Santander

41013

Hospital Universitario Virgen del Rocío, Seville

08036

Hospital Clinic, Barcelona

All Listed Sponsors
collaborator

Instituto de Investigación Biomédica de Salamanca

OTHER

collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

OTHER

NCT02491671 - Effectiveness Novel Tissue Sealant, Prevention Prolonged Air Leak (PAL) After Lung Resection | Biotech Hunter | Biotech Hunter